Ancestry specific distribution of LPA Kringle IV-Type-2 genetic variants highlight associations to apo(a) copy number, glucose and hypertension.

Yihao Li,Florian Kronenberg,Stefan Coassin,Badri Vardarajan,Gissette Reyes-Soffer

DOI: https://doi.org/10.1101/2024.07.09.24310176

2024-07-10

Abstract:Background: High Lp(a) levels contribute to atherosclerotic cardiovascular disease and are tightly regulated by the LPA gene . Lp(a) levels have an inverse correlation with LPA Kringle IV Type-2 (KIV-2) copy number (CN). Black (B) and Hispanic (H) individuals exhibit higher levels of Lp(a) and rates of CVD compared to non-Hispanic Whites (NHW). Therefore, we investigated genetic variations in the LPA KIV-2 region across three ancestries and their associations with metabolic risk factors. Methods: Using published pipelines we analyzed a multi-ethnic whole exome dataset comprising 3,817 participants from the Washington Heights and Inwood Columbia Aging Project (WHICAP): 886 [NHW (23%), 1,811 Caribbean (C) H (47%), and 1,120 B individuals (29%). Rare and common variants (alternative allele carrier frequency, CF < 0.01 or > 0.99 and 0.01 < CF < 0.99, respectively) were identified and KIV-2 CN estimated. The associations of variants and CN with: history of heart disease, hypertension (HTN), stroke, lipid levels and, clinical diagnosis of Alzheimer?s disease (AD) wasassessed. A small pilot provided in-silico validation of study findings. Results: We report 1421 variants in the LPA KIV-2 repeat region, comprising 267 exonic and 1154 intronic variants. 61.4% of the exonic variants have not been previously described. Three novel exonic variants significantly increase the risk of HTN across all ethnic groups: 4785-C/A (frequency = 78%, odds ratio [OR] = 1.45, p = 0.032), 727-T/C (frequency = 96%, OR = 2.11, p = 0.032), and 723-A/G (frequency = 96%, OR = 1.97, p = 0.038). Additionally, six intronic variants showed associations with HTN: 166-G/A, 387-G/C, 402-G/A, 4527-A/T, 4541-G/A, and 4653-A/T. One intronic variant, 412-C/T, was associated with decreased blood glucose levels (frequency = 72%, ? = -14.52, p = 0.02). Three of the associations were not affected after adjusting for LPA KIV-2 CN: 412-C/T (? = -14.2, p = 0.03), 166-G/A (OR = 1.41, p = 0.05), and 387-G/C (OR = 1.40, p = 0.05). KIV CN itself was significantly associated with 314 variants and was negatively correlated with plasma total cholesterol levels. Conclusions: In three ancestry groups, we identify novel rare and common LPA KIV-2 region variants. We report new associations of variants with HTN and Glucose levels. These results underscore the genetic complexity of the LPA KIV-2 region in influencing cardiovascular and metabolic health, suggesting potential genetic regulation of pathways that can be studied for research and therapeutic interventions.

Cardiovascular Medicine

What problem does this paper attempt to address?

The paper mainly discusses the distribution of genetic variations in the Kringle IV-Type-2 (KIV-2) region of the LPA gene in different ethnic groups and their associations with metabolic phenotypes such as lipoprotein(a) (Lp(a)) levels, blood glucose, and hypertension. The study used a multi-ethnic exome sequencing dataset including non-Hispanic white, Caribbean black, and black individuals. The study identified 1421 rare and common variations in the KIV-2 region, and some specific variations were strongly associated with hypertension, while an intronic variation was associated with lower blood glucose levels. These findings reveal the impact of genetic complexity in the LPA KIV-2 region on cardiovascular and metabolic health, providing potential genetic regulatory pathways for future research and therapeutic interventions.